ImmunityBio, Inc. (IBRX) on GreekSoup https://greeksoup.ai/stocks/us/ibrx/ Every dated entry in the public record on ImmunityBio, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 ImmunityBio, Inc.: short interest 122,945,839 shares at the 15 October 2026 settlement, 7.15 days to coverhttps://greeksoup.ai/stocks/us/ibrx/short-interest/us:IBRX:short-interest:2026-10-15:309dfb8743Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> ImmunityBio, Inc. filed 8-K: regulation fd disclosurehttps://greeksoup.ai/stocks/us/ibrx/filings/us:IBRX:filing:2026-10-14:0553e5a0a0Wed, 14 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> ImmunityBio, Inc.: Lisa McClain (MI09) disclosed a purchase, $1,001 - $15,000, traded 30 September 2026https://greeksoup.ai/stocks/us/ibrx/congress/us:IBRX:congress:2026-10-12:f3aa5910d3Mon, 12 Oct 2026 00:00:00 +0000House tradeHouse trade. The filing. The page on GreekSoup.

]]> ImmunityBio, Inc.: Lisa McClain (MI09) disclosed a purchase, $1,001 - $15,000, traded 28 September 2026https://greeksoup.ai/stocks/us/ibrx/congress/us:IBRX:congress:2026-10-12:80cfbd7fc9Mon, 12 Oct 2026 00:00:00 +0000House tradeHouse trade. The filing. The page on GreekSoup.

]]> ImmunityBio, Inc.: Simon Barry J. (Director) sold 25,000 shares (under a trading plan set in advance) at $10.75 on 5 October 2026, $268,760https://greeksoup.ai/stocks/us/ibrx/insiders/us:IBRX:insider:2026-10-06:25f5295a68Tue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> ImmunityBio, Inc.: Cohen Cheryl (Director) sold 81,056 shares (under a trading plan set in advance) at $10.50 on 2 October 2026, $851,088https://greeksoup.ai/stocks/us/ibrx/insiders/us:IBRX:insider:2026-10-06:168e647c8bTue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> ImmunityBio, Inc.: Form 144, Simon Barry J. plans to sell 560,000 shares worth $7.7 million around 5 October 2026https://greeksoup.ai/stocks/us/ibrx/planned-sales/us:IBRX:planned-sale:2026-10-05:e6de2e0d42Mon, 05 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> ImmunityBio, Inc.: Form 144, CHERYL COHEN plans to sell 81,056 shares worth $752,200 around 2 October 2026https://greeksoup.ai/stocks/us/ibrx/planned-sales/us:IBRX:planned-sale:2026-10-02:ff44618a0fFri, 02 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> ImmunityBio, Inc.: short interest 124,092,202 shares at the 30 September 2026 settlement, 8.88 days to coverhttps://greeksoup.ai/stocks/us/ibrx/short-interest/us:IBRX:short-interest:2026-09-30:d7ff7e438cWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> ImmunityBio, Inc.: short interest 125,408,192 shares at the 15 September 2026 settlement, 15.86 days to coverhttps://greeksoup.ai/stocks/us/ibrx/short-interest/us:IBRX:short-interest:2026-09-15:8fe66518dcTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> ImmunityBio, Inc.: short interest 125,637,933 shares at the 31 August 2026 settlement, 14.77 days to coverhttps://greeksoup.ai/stocks/us/ibrx/short-interest/us:IBRX:short-interest:2026-08-31:9444133cf0Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> ImmunityBio, Inc.: short interest 127,495,672 shares at the 14 August 2026 settlement, 15.44 days to coverhttps://greeksoup.ai/stocks/us/ibrx/short-interest/us:IBRX:short-interest:2026-08-14:9127bd33deFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> ImmunityBio, Inc.: Schedule 13D/A filed by Cambridge Equities, LP, 64.8% of the classhttps://greeksoup.ai/stocks/us/ibrx/holders/us:IBRX:schedule-13:2026-08-06:048306207dThu, 06 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> ImmunityBio, Inc. Q2 FY2026 results: revenue $51 million, net income -$230 millionhttps://greeksoup.ai/stocks/us/ibrx/results/fy2026-q2/us:IBRX:result:2026-08-04:44f2f6ed0fTue, 04 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> ImmunityBio, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/ibrx/filings/us:IBRX:filing:2026-08-04:4b8a84f884Tue, 04 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> ImmunityBio, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/ibrx/filings/us:IBRX:filing:2026-08-04:cb2a5e02abTue, 04 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> ImmunityBio, Inc.: short interest 128,997,049 shares at the 31 July 2026 settlement, 14.49 days to coverhttps://greeksoup.ai/stocks/us/ibrx/short-interest/us:IBRX:short-interest:2026-07-31:743ea2280dFri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> ImmunityBio, Inc. filed 8-K: regulation fd disclosurehttps://greeksoup.ai/stocks/us/ibrx/filings/us:IBRX:filing:2026-07-30:ebbe8bc15cThu, 30 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>